Advertisement
Advertisement
GRCE
Grace Therapeutics, Inc. Common Stock
2.33
USDSponsored
-0.06
-2.51%
Jun 24, 16:00 UTC -4
Closed
After-Market
2.33
0.00
0.00%
GRCE Earnings Reports
Positive Surprise Ratio
GRCE beat 15 of 23 last estimates.
65%
Next Report
Date of Next Report
--
Estimate for Q-- -- (Revenue/ EPS)
--
/--
Implied change from Q4 26 (Revenue/ EPS)
--
/--
Implied change from Q-- -- (Revenue/ EPS)
--
/--
Grace Therapeutics, Inc. Common Stock earnings per share and revenue
On Jun 23, 2026, GRCE reported earnings of -- USD per share (EPS) for Q4 26, -- the estimate of -0.23 USD, resulting in a --% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference.
Looking ahead to -- --, -- analysts forecast an EPS of -- USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Vistagen Therapeutics, Inc. Common Stock
Report Date
Jun 15, 2026 For Q4 26
Estimate
-$0.34
Actual
-$0.37
Surprise
-7.75%
enGene Therapeutics Inc. Common Stock
Report Date
Jun 15, 2026 For Q2 26
Estimate
-$0.47
Actual
-$0.43
Surprise
+10.32%
Prenetics Global Limited Class A Ordinary Share
Report Date
Jun 10, 2026 For Q1 26
Estimate
-$1.10
Actual
-$1.61
Surprise
-45.36%
Anixa Biosciences, Inc.
Report Date
Jun 10, 2026 For Q2 26
Estimate
-$0.08
Actual
-$0.07
Surprise
+21.61%
FAQ
What were Grace Therapeutics, Inc. Common Stock's earnings and revenue for the latest quarter Q4 2026?
For Q4 2026, Grace Therapeutics, Inc. Common Stock reported EPS of --, missing estimates by --, and revenue of --, 0% as expectations.
How did the market react to Grace Therapeutics, Inc. Common Stock's Q4 2026 earnings?
The stock price moved -- --, changed from -- before the earnings release to -- the day after.
When is Grace Therapeutics, Inc. Common Stock expected to report next?
The next earning report is scheduled for --.
What are the forecasts for Grace Therapeutics, Inc. Common Stock's next earnings report?
Based on --
analysts, Grace Therapeutics, Inc. Common Stock is expected to report EPS of -- and revenue of -- for Q-- --.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement